NasdaqGS:COLLPharmaceuticals
Is It Too Late To Consider Collegium Pharmaceutical (COLL) After A 40% One Year Gain?
Investors may be asking whether Collegium Pharmaceutical at around US$46.90 is offering good value right now, or if most of the upside has already been priced in.
The share price has seen mixed recent returns, with a 3.9% decline over the past week and a 3.7% decline over the past month, while still sitting on a 40.2% return over 1 year and 98.6% over 5 years.
Recent coverage has focused on how investors are reassessing specialty pharmaceutical names like Collegium Pharmaceutical in light of...